| Jan 26, 2026 |
An international research team has demonstrated that Janus nanoparticles can disrupt the defenses of drug-resistant Gram-negative bacteria, restoring the effectiveness of conventional antibiotic treatments.
(Nanowerk News) In the global battle against antimicrobial resistance (AMR), an international research team has unveiled a powerful new game-changer. Using distinctive “two-faced” Janus nanoparticles, the team demonstrated a strategy that works in tandem with antibiotics to overcome the defenses of highly resistant Gram-negative bacteria. These particles disrupt the bacteria’s protective outer membrane, creating an entry point for drugs that were previously ineffective and thereby reviving their life-saving potential.
|
|
The findings have been published in Nano Letters (“Amphiphilic Janus Nanoparticles Synergize with Antibiotics to Restore Susceptibility in Drug-Resistant Gram-Negative Bacteria”).
|
 |
| Bacteria (gray) exhibit resistance to antibiotics (green spheres). However, when Janus nanoparticles (orange/gray spheres) are added, the antibiotics penetrate into the bacteria (red), leading to bacterial cell death. (Image: University of Osaka)
|
|
Antimicrobial resistance is a severe global health crisis, with drug-resistant Gram-negative bacteria posing a particular challenge. These microbes are encased in a formidable outer membrane that acts as a shield, blocking many antibiotics from reaching their targets within the cell. This natural armor is a key reason why developing new drugs against them is so difficult and why existing ones are rapidly losing their power, leaving doctors with few treatment options.
|
|
Associate Professor Martijn Zwama and Professor Kunihiko Nishino led the research at the Institute of Scientific and Industrial Research (SANKEN), The University of Osaka, in collaboration with Professor Yan Yu (Indiana University, USA; current position: Washington University in St. Louis, USA), who led the design and engineering of the amphiphilic Janus nanoparticles (JNPs).
|
|
Named after the two-faced Roman god, these particles have a dual nature: one side is hydrophilic (attracted to water) and the other is hydrophobic (repels water). This structure allows the JNPs to interact with and destabilize the bacterial outer membrane. While the JNPs themselves are not lethal to the bacteria, they effectively create pores or disruptions on the surface, compromising the cell’s main defensive wall.
|
|
This breach allows conventional antibiotic molecules, which were once blocked, to flood into the cell and execute their bacteria-killing function. This synergistic approach restored antibiotic activity against drug-resistant Gram-negative pathogens, including Escherichia coli and clinical isolates of Acinetobacter baumannii, a major cause of hospital-acquired infections.
|
|
This study offers a breakthrough materials-based strategy against antimicrobial resistance. By physically disrupting bacterial membranes, these nanoparticles are less susceptible to resistance evolution. They act as potent adjuvants, reviving and extending the lifespan of many existing antibiotics. This approach not only addresses a critical global health crisis but also opens doors for new clinical applications, such as antibacterial coatings, providing a versatile and high-impact tool to combat multidrug-resistant infections worldwide.
|
|
“These nanoparticles act as a perfect partner for antibiotics,” says lead author Dr. Martijn Zwama. “They don’t kill the bacteria directly but rather open the door for antibiotics to do their job. This synergy overcame resistance in some of the most stubborn bacteria. This approach of ‘reviving’ antibiotics offers a promising and sustainable path forward in tackling the AMR crisis.”
|
